AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2011
Jun 2, 2011
33510_dirs_2011-06-02_e6228d00-62a4-4b5a-8a40-12b98cc89d1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2011-05-25
Reporting Person: Ragle Brien (Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-26 | Common Stock | M | 11333 | $0.26 | Acquired | 11333 | Direct |
| 2011-05-25 | Common Stock | S | 6106 | $1 | Disposed | 5227 | Direct |
| 2011-05-25 | Common Stock | S | 1000 | $1.01 | Disposed | 4227 | Direct |
| 2011-05-26 | Common Stock | S | 4227 | $1 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-26 | Stock Option | $0.26 | M | 11333 | Disposed | 2019-06-01 | Common Stock (11333) | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16